OpenLobby.EU

Bayer AG

Bayer is a life science company with over 150 years of history, operating in healthcare and agriculture through its Pharmaceuticals, Consumer Health, and Crop Science divisions.

Lobbying Activity

Meeting with Estelle Goeger (Cabinet of Executive Vice-President Stéphane Séjourné) and

4 Nov 2025 · Overview of the Commission's Single Market Strategy.

Meeting with Dorota Denning (Cabinet of Commissioner Valdis Dombrovskis) and

28 Oct 2025 · Roundtable on Simplification for Pharmaceutical Innovation

Meeting with Dorota Denning (Cabinet of Commissioner Valdis Dombrovskis) and

28 Oct 2025 · Roundtable on Simplification for Agricultural Innovation

Meeting with Liesbet Sommen (Member of the European Parliament) and

23 Oct 2025 · Pharmaceutical legislation + Critical Medicines Act

Meeting with Hildegard Bentele (Member of the European Parliament)

17 Oct 2025 · Biotech Act

Meeting with Jan Hendrik Dopheide (Cabinet of Commissioner Maroš Šefčovič)

15 Oct 2025 · EU-UK relations

Bayer urges EU to speed up pesticide approvals and protect conventional chemicals

14 Oct 2025
Feedback on — EU consultation on simplifying food and feed safety regulations and plant protection product authorizations.
Their ask — Bayer requests the EU reform hazard-based cut-off criteria that automatically ban substances, modernize endocrine disruptor assessments, and streamline authorization processes for both conventional and biological pesticides. They want emergency authorizations extended beyond 120 days and converted to standard approvals when repeatedly needed.1234
How it helps them — This would protect Bayer's existing chemical products from withdrawal and reduce approval costs and delays.567
Who loses — Environmental and consumer groups lose stronger protections against endocrine disruptors and hazardous chemicals.8
Response to: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) 1107/2009, Regulation (EC) No 396/2005, Regulation (EU) 528/2012, Regulation (EC) 1831/2003, Regulation (EC) No 852/2004, Regulation (EC) No 853/2004, Regulation 1099/2009, Regulation (EC) No 999/2001, Regulation (EC) No 1069/2009, Regulation (EU) 2017/625 and Directive 98/58/EC, as regards simplifying and clarifying food and feed safety requirements

Bayer urges AI research exemption and data simplification

14 Oct 2025
Feedback on — Digital Omnibus revising EU rules on AI, data protection, and cybersecurity.
Their ask — Bayer requests clarification that AI used across the medicine lifecycle qualifies under the Article 2(6) research exemption. They want harmonized data protection rules aligned with GDPR and a one-stop-shop for cyber incident reporting. They seek EU-managed AI cloud infrastructure and increased funding for public-private partnerships in health and agriculture.1234
How it helps them — This would reduce compliance burden and allow faster AI deployment in drug development.56
Who loses — Consumer and patient groups lose stronger AI safety oversight and transparency protections.
Response to: Digital Omnibus revising several legislative acts in view of regulatory simplification

Meeting with Rainer Becker (Director Health and Food Safety)

9 Oct 2025 · Bilateral meeting in the margins of the Copenhagen Life Science Summit

Meeting with Martin Seychell (Deputy Director-General Directorate-General for International Partnerships)

9 Oct 2025 · Bayer strategic approach for the African market

Meeting with Irene Sacristan Sanchez (Head of Unit Health and Food Safety) and

9 Oct 2025 · Exchange of views on the state of play of the interinstitutional negotiations on the Commission proposal for a Regulation on plants obtained by certain new genomic techniques (NGT proposal)

Meeting with Veronika Vrecionová (Member of the European Parliament, Committee chair)

8 Oct 2025 · Gene editing and innovation in agriculture

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

8 Oct 2025 · Medicine market

Meeting with Esther Herranz García (Member of the European Parliament)

8 Oct 2025 · NGTs

Meeting with Valérie Hayer (Member of the European Parliament)

8 Oct 2025 · NGTs

Meeting with Norbert Lins (Member of the European Parliament)

8 Oct 2025 · NGTs

Meeting with Pietro Fiocchi (Member of the European Parliament, Shadow rapporteur)

7 Oct 2025 · NGT

Meeting with Hildegard Bentele (Member of the European Parliament)

7 Oct 2025 · Biotech and Water

Meeting with Andreas Glück (Member of the European Parliament)

7 Oct 2025 · NGTs

Meeting with Oliver Schenk (Member of the European Parliament)

7 Oct 2025 · Pharmaceutical Industry in the EU

Meeting with Jan-Christoph Oetjen (Member of the European Parliament)

7 Oct 2025 · Exchange on agriculture sector and new innovations

Bayer demands innovation stress test to accelerate EU approvals

3 Oct 2025
Feedback on — EU framework to remove barriers for innovative companies and attract investors.
Their ask — Bayer requests an Innovation Stress Test to ensure regulations enable rather than constrain R&D. They want EU-level regulatory sandboxes, faster permitting processes, and streamlined financing access. The company seeks targeted support for innovation hubs and sector-specific investment incentives.123
How it helps them — This would reduce regulatory burdens and speed market entry where approvals are significantly faster globally.45
Who loses — Consumer and environmental groups lose stronger oversight of agricultural and pharmaceutical products.67
Response to: Regulation of the European Parliament and of the Council establishing a framework of measures for strengthening Europe’s innovation ecosystem

Meeting with Olga Solomon (Head of Unit Health and Food Safety) and

3 Oct 2025 · The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition.

Bayer urges EU to align nature credits with carbon farming framework

26 Sept 2025
Feedback on — EU roadmap for establishing a voluntary nature credit certification system.
Their ask — Bayer requests integration of nature credits into existing frameworks like the Carbon Removal Certification Framework and the planned agricultural sustainability compass. They advocate for outcome-based certification covering multiple nature outcomes including endangered species, habitats, and ecosystem services, with flexibility through different credit types and quality tiers.123
How it helps them — This would create business opportunities for their carbon and regenerative agricultural services division.45
Who loses — Environmental groups lose if nature credits allow offsetting rather than requiring direct biodiversity improvements.6
Response to: COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Roadmap towards Nature Credits

Meeting with Elisabeth Werner (Director-General Agriculture and Rural Development)

12 Sept 2025 · Exchange of views on the ongoing simplification efforts, legislative proposals related to the company’s activities, innovation and resilience

Meeting with Flavio Facioni (Cabinet of Commissioner Olivér Várhelyi)

11 Sept 2025 · Simplification and competitiveness in the agri-food sector

Bayer urges outcome-based farm policy to boost climate resilience

2 Sept 2025
Feedback on — EU regulation establishing framework for climate preparedness, resilience and risk management.
Their ask — Bayer requests transition to an outcome-based agricultural policy framework that is inclusive of all tools and practices. They seek simplification of existing regulations to improve access to plant breeding innovation, pesticides, and digital agriculture. They emphasize the need for open trade to ensure resilient agricultural supply chains.1234
How it helps them — This would give farmers access to all crop protection tools and maintain market competitiveness.56
Who loses — Environmental groups lose stricter controls on pesticide hazards and GM crops.78
Response to: Proposal for a Regulation of the European Parliament and of the Council establishing the framework for achieving climate preparedness and resilience and laying down harmonised rules on climate risk management, and amending Regulation (EU) 2018/1999 on the Governance of the Energy Union and Climate Action

Bayer urges EU to prioritize menopause in gender equality strategy

11 Aug 2025
Feedback on — EU consultation on its next five-year Gender Equality Strategy 2026-2030.
Their ask — Bayer calls for menopause to be embedded as a core pillar in the strategy, with investments in research, education, and awareness campaigns. The company seeks harmonized policies ensuring equitable access to both hormonal and innovative non-hormonal therapies across Member States. They recommend workplace inclusion measures and expanded data collection on menopause's socioeconomic impacts.1234
How it helps them — This would expand the market for Bayer's menopause therapies across Europe.567
Who loses — National health budgets face increased costs from expanded treatment coverage and research.89
Response to: COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Gender Equality Strategy 2026-2030

Meeting with Chiara Galiffa (Cabinet of Commissioner Maroš Šefčovič)

11 Jul 2025 · EU-US relations

Meeting with Maroš Šefčovič (Commissioner) and

11 Jul 2025 · Implementation dialogue on customs legislation - Rules of origin

Bayer urges bioeconomy targets and regulatory reform for agricultural innovation

20 Jun 2025
Feedback on — EU strategy for circular, regenerative and competitive bioeconomy across sectors.
Their ask — Bayer requests outcome-based sustainability criteria for biomass, compliance targets for biobased resources across sectors, and regulatory reform enabling access to plant breeding innovation, pesticides, and digital tools. They advocate transitioning from hazard-based to risk-based pesticide regulation and excluding certain genomic techniques from GMO restrictions.12345
How it helps them — This would reduce regulatory burden on their agricultural products and expand markets for seeds and pesticides.678
Who loses — Environmental and health advocates lose stronger hazard-based protections against pesticide risks and GMO safeguards.9
Response to: Communication on a new EU Bioeconomy strategy: Towards a Circular, Regenerative and Competitive Bioeconomy

Meeting with Daniel Freund (Member of the European Parliament) and Currenta GmbH & Co. OHG

13 Jun 2025 · Austausch

Meeting with Astrid Dentler (Cabinet of Commissioner Wopke Hoekstra), Miguel Jose Garcia Jones (Cabinet of Commissioner Wopke Hoekstra)

12 Jun 2025 · Discussion on sustainable competitiveness.

Bayer urges simplification and IP protection in EU Biotech Act

11 Jun 2025
Feedback on — EU proposal to create enabling environment for biotechnology from lab to market.
Their ask — Bayer requests stronger intellectual property protections, streamlined approval processes at EFSA and EMA, future-proof regulations for genome-edited plants, and a comprehensive social dialogue on biotechnology. They emphasize the Act should simplify existing rules rather than add new layers.1234
How it helps them — This would reduce regulatory costs and timelines while protecting their proprietary biotechnology innovations.567
Who loses — Generic competitors lose ability to leverage Bayer's regulatory data for faster market entry.8
Response to: Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

Meeting with Stéphane Séjourné (Executive Vice-President) and

11 Jun 2025 · An exchange on Europe’s pharmaceutical & life sciences sectors

Meeting with Michael Hager (Cabinet of Commissioner Valdis Dombrovskis)

10 Jun 2025 · Simplification

Bayer urges AI research exemption for pharmaceutical development

5 Jun 2025
Feedback on — European strategy for AI adoption in science and research council establishment.
Their ask — Bayer requests exemption of AI systems used solely for medicines R&D from EU AI Act requirements. They advocate for clearer guidelines on the R&D exemption and simplification of overlapping regulatory frameworks across GDPR, Data Act, and AI Act. The company seeks harmonized regulations across jurisdictions and regulatory oversight centralized within EMA.123
How it helps them — This would reduce compliance burdens and allow faster AI experimentation in drug development.45
Who loses — European patients lose access as systems launch overseas due to complex EU requirements.6
Response to: COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS: A European Strategy for AI in science – paving the way for a European AI research council

Bayer calls for simplified AI regulation to accelerate drug discovery

4 Jun 2025
Feedback on — EU strategy for AI adoption across strategic sectors including healthcare.
Their ask — Bayer requests simplified AI regulation with clear guidance on responsible healthcare AI use. They want expanded regulatory sandboxes for biopharma testing and continued public-private collaboration funding. The company emphasizes flexible technology standards focused on outcomes rather than rigid requirements.123
How it helps them — This would reduce regulatory complexity and accelerate their AI-driven drug development.45
Response to: Apply AI Strategy: strengthening the AI continent

Meeting with Angelika Niebler (Member of the European Parliament)

3 Jun 2025 · EU’s General Pharmaceutical Legislation

Meeting with Cynthia Ní Mhurchú (Member of the European Parliament)

3 Jun 2025 · Menopause Matters: Investing in Women's Health for the Future

Meeting with Svenja Hahn (Member of the European Parliament)

20 May 2025 · Introductory Meeting

Meeting with Veronika Vrecionová (Member of the European Parliament, Committee chair)

15 May 2025 · NGTs

Meeting with Antonella Rossetti (Cabinet of Commissioner Christophe Hansen), Taru Haapaniemi (Cabinet of Commissioner Christophe Hansen)

14 May 2025 · Opportunities for simplification to strengthen competitiveness of European farming; The future of plant biotechnology as a basis for strengthening bioeconomy in Europe; Digital tools and use of AI in farming systems

Bayer urges EU to boost biotech competitiveness through funding and regulatory reform

16 Apr 2025
Feedback on — EU strategy to strengthen life sciences competitiveness and reduce dependencies on global competitors.
Their ask — Bayer requests targeted funding for innovation hubs, streamlined approval processes for biotech products, and stronger intellectual property protections. They advocate for creating a dedicated EU Life Sciences Office to coordinate policy and ensure regulatory frameworks support innovation rather than hinder it.123
How it helps them — This would reduce lengthy approval timelines and compliance costs while protecting their proprietary research investments.456
Who loses — Environmental and consumer groups lose stricter chemical regulations and hazard-based safety protections.7
Response to: Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

Meeting with Oihane Agirregoitia Martínez (Member of the European Parliament)

8 Apr 2025 · Biotecnología y la competitividad industrial

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and

4 Apr 2025 · Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Meeting with Felix Fernandez-Shaw (Director Directorate-General for International Partnerships) and

1 Apr 2025 · Plenary Feedback round on previously held GGIA Working Group sessions of 9 different thematical groups regarding Latin America and the Caribbean (LAC).

Meeting with Alexander Bernhuber (Member of the European Parliament)

1 Apr 2025 · Pflanzenschutzmittel

Meeting with Pietro Fiocchi (Member of the European Parliament)

26 Mar 2025 · Strategia farmaceutica europea

Meeting with Veronika Cifrová Ostrihoňová (Member of the European Parliament)

26 Mar 2025 · Women's health and medicine shortages in the EU

Meeting with Morten Løkkegaard (Member of the European Parliament, Shadow rapporteur)

26 Mar 2025 · Biotechnology & Simplification

Meeting with Marta Temido (Member of the European Parliament)

26 Mar 2025 · Sector farmaceutico, e politíca industrial no contexto europeu

Meeting with Oliver Schenk (Member of the European Parliament)

26 Mar 2025 · Pharmaceutical Industry in the EU

Meeting with Alice Teodorescu Måwe (Member of the European Parliament)

26 Mar 2025 · Pharmaceuticals

Meeting with Sunčana Glavak (Member of the European Parliament)

26 Mar 2025 · European industrial policy

Meeting with Susana Solís Pérez (Member of the European Parliament)

26 Mar 2025 · European industrial regulation

Meeting with Dimitris Tsiodras (Member of the European Parliament)

26 Mar 2025 · EU health and research policies

Meeting with Elena Sancho Murillo (Member of the European Parliament)

26 Mar 2025 · Relevant issues to the AGRI Committee

Meeting with Elsi Katainen (Member of the European Parliament)

26 Mar 2025 · Topical issues in the pharmaceutical sector

Meeting with Eero Heinäluoma (Member of the European Parliament, Shadow rapporteur)

26 Mar 2025 · Bioteknologia ja teollisuuden kilpailukyky

Meeting with Stefan Berger (Member of the European Parliament)

25 Mar 2025 · Biotechnology

Meeting with Irene Sacristan Sanchez (Head of Unit Health and Food Safety) and

25 Mar 2025 · Policy developments relevant to European seed sector (proposal on plants obtained by certain new genomic techniques, NGTs)

Meeting with Maria Walsh (Member of the European Parliament)

25 Mar 2025 · Agricultural policy

Bayer seeks regulatory relief for medical devices in drug trials

20 Mar 2025
Feedback on — Evaluation of EU regulations on medical devices and in vitro diagnostics.
Their ask — Bayer requests exemptions from distributor verification requirements for medical devices co-packaged with medicines, clarification that repackaging such devices doesn't trigger manufacturer obligations, and allowance for in-house diagnostic testing outside the EU for clinical trials. They seek to remove notification requirements when using leftover samples in performance studies already approved through CTIS.123
How it helps them — This would reduce handling costs and delays in the supply chain for combination products.45
Who loses — Patient safety oversight loses additional verification checkpoints in the distribution chain.6
Response to: Targeted evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostics

Meeting with Vita Jukne (Cabinet of Commissioner Jessika Roswall)

20 Mar 2025 · Chemicals legislation

Meeting with Olivér Várhelyi (Commissioner) and

19 Mar 2025 · EU health policy

Meeting with Sabine Weyand (Director-General Trade)

19 Mar 2025 · Global trade developments, state of play and next steps.

Bayer Seeks Stronger Plant Variety Rights and Farm Seed Restrictions

14 Mar 2025
Feedback on — Evaluation of EU regulation on intellectual property rights for plant varieties.
Their ask — Bayer requests stronger protections for essentially-derived varieties aligned with UPOV guidance, rebalancing of farm-saved seed compensation where usage reaches 50% of planted areas, and expansion of distinctness criteria to include disease resistance and nutritional traits developed through new genomic techniques.123
How it helps them — This would protect their breeding investments and enable royalties from NGT innovations currently unprotectable.45
Who loses — Farmers lose affordable seed reuse rights as compensation costs could rise significantly.6
Response to: Evaluation of Council Regulation (EC) No 2100/94 of 27 July 1994 on Community plant variety rights

Meeting with Ana Vasconcelos (Member of the European Parliament)

13 Mar 2025 · NGTs

Meeting with Asger Christensen (Member of the European Parliament)

12 Mar 2025 · NGT

Meeting with Cecile Billaux (Head of Unit Directorate-General for International Partnerships)

28 Feb 2025 · Overview of Bayer’s international and EU initiatives and presentation of DG INTPA activity on health in the international dimension

Bayer Urges Thorough Impact Assessment Before Critical Medicines Act

27 Feb 2025
Feedback on — EU legislation to address supply chain vulnerabilities and shortages of critical medicines.
Their ask — Bayer requests a thorough impact assessment before publication and streamlined administrative requirements. They want the Act to avoid duplication between national and EU systems. Any incentives for EU manufacturing should consider existing regulations and prioritize existing facilities with competitive advantages.1234
How it helps them — This would reduce administrative costs and protect existing European manufacturing investments.56
Who loses — Generic medicine suppliers face stricter requirements while innovative medicines experience fewer disruptions.7
Response to: Critical Medicines Act

Meeting with Olivér Várhelyi (Commissioner) and

26 Feb 2025 · Healthcare, biotech and agri-food policies

Meeting with Maroš Šefčovič (Commissioner) and

15 Feb 2025 · Introductory meeting / trade policy with a focus on EU-US

Meeting with Wopke Hoekstra (Commissioner) and

14 Feb 2025 · Clean Industrial Deal

Meeting with Gabriela Tschirkova (Cabinet of Commissioner Valdis Dombrovskis)

14 Feb 2025 · Simplification - agricolture, pharma, sustainability reporting, Taxonomy

Meeting with Antonella Rossetti (Cabinet of Commissioner Christophe Hansen), Maxi Espeter (Cabinet of Commissioner Christophe Hansen)

13 Feb 2025 · Mutual introduction exchange on key policy priorities in the agricultural sector

Meeting with Flavio Facioni (Cabinet of Commissioner Olivér Várhelyi), Laszlo Andrejko (Cabinet of Commissioner Olivér Várhelyi)

5 Feb 2025 · EU health policy

Meeting with Gabriele Bischoff (Member of the European Parliament, Shadow rapporteur) and

24 Jan 2025 · Austausch mit dem Wirtschaftsforum der SPD e.V. zur Revision Eurobetriebsräte

Meeting with Peter Liese (Member of the European Parliament) and Pharma Deutschland e.V

12 Dec 2024 · Austausch

Meeting with Bernd Lange (Member of the European Parliament, Committee chair)

4 Dec 2024 · General Exchange of View

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

3 Dec 2024 · New EU Pharmaceutical Legislation

Meeting with Michael Hager (Cabinet of Commissioner Valdis Dombrovskis)

2 Dec 2024 · Simplification

Meeting with Andreas Glück (Member of the European Parliament) and Carl Zeiss AG

21 Nov 2024 · Environmental Policy

Meeting with Stefan Köhler (Member of the European Parliament) and

23 Oct 2024 · Politischer Austausch

Meeting with Michalis Hadjipantela (Member of the European Parliament) and TotalEnergies SE

22 Oct 2024 · Introductory Meeting

Meeting with Wouter Beke (Member of the European Parliament)

18 Oct 2024 · Sustainable competitiveness

Meeting with Martin Häusling (Member of the European Parliament)

16 Oct 2024 · Gespräch mit Vertreter*innen von Bayer zu Innovation, Nachhaltigkeit und Wirtschaftskraft

Meeting with Katri Kulmuni (Member of the European Parliament) and

16 Oct 2024 · Ajankohtaiset EU-lakihankkeet

Response to Commission Roadmap towards ultimately phasing out animal testing for chemical safety assessments

15 Oct 2024

Meeting with Vytenis Povilas Andriukaitis (Member of the European Parliament)

15 Oct 2024 · EU health policy

Meeting with Peter Van Kemseke (Cabinet of President Ursula von der Leyen)

10 Oct 2024 · EB Summit

Meeting with Dan-Ştefan Motreanu (Member of the European Parliament)

3 Oct 2024 · The strategic dialogue on the future of agriculture and the future vision on agriculture

Meeting with Daniel Buda (Member of the European Parliament)

3 Oct 2024 · The strategic dialogue on the future of agriculture and the future vision on agriculture

Meeting with Jens Geier (Member of the European Parliament)

18 Sept 2024 · General Exchange on the new legislative term

Meeting with Stefan Köhler (Member of the European Parliament) and

18 Sept 2024 · Politischer Austausch

Meeting with András Tivadar Kulja (Member of the European Parliament)

10 Sept 2024 · European Healthcare

Meeting with Norbert Lins (Member of the European Parliament)

24 Jul 2024 · Exchange on relevant topics for the new legislative period

Meeting with Alexander Bernhuber (Member of the European Parliament)

22 Jul 2024 · Outlook on priorities in COM AGRI and COM ENVI

Meeting with Kathleen Van Brempt (Member of the European Parliament)

2 Jul 2024 · sustainable agriculture/pesticides/NGTs

Meeting with Anna Cavazzini (Member of the European Parliament)

7 May 2024 · Nachhaltige Landwirtschaft

Meeting with Damian Boeselager (Member of the European Parliament)

6 May 2024 · EU Elections Event

Meeting with Alexandra Geese (Member of the European Parliament) and

9 Apr 2024 · European Elections

Meeting with Terry Reintke (Member of the European Parliament)

18 Mar 2024 · Green Deal, Industrial Policies

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and European Confederation of Pharmaceutical Entrepreneurs

7 Mar 2024 · Directive on Medicinal products for human use

Meeting with Dolors Montserrat (Member of the European Parliament)

6 Mar 2024 · Revision of the pharmaceutical legislation

Meeting with Sunčana Glavak (Member of the European Parliament)

29 Feb 2024 · Pharma package

Meeting with Mauri Pekkarinen (Member of the European Parliament)

28 Feb 2024 · Discussion on health care related issues

Meeting with Jan-Christoph Oetjen (Member of the European Parliament)

28 Feb 2024 · Competitiveness of European Industry

Meeting with Andreas Glück (Member of the European Parliament)

28 Feb 2024 · Pharma-Paket

Meeting with Anna Cavazzini (Member of the European Parliament, Committee chair) and

23 Feb 2024 · Aktuelle Themen in der Europapolitik und Sachsen

Meeting with Wopke Hoekstra (Commissioner)

17 Feb 2024 · Latest developments on EU climate policy

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion)

16 Feb 2024 · Pharmaceutical Package

Meeting with Peter Liese (Member of the European Parliament)

23 Jan 2024 · Austausch

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion)

17 Jan 2024 · Pharmaceutical Package (Regulation)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and

12 Dec 2023 · Directive on Medicinal products for human use

Meeting with Izaskun Bilbao Barandica (Member of the European Parliament)

21 Nov 2023 · Acuerdo Mercosur

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

21 Nov 2023 · Medicines

Meeting with Gabriel Mato (Member of the European Parliament)

21 Nov 2023 · Meeting about Mercosur

Meeting with Asger Christensen (Member of the European Parliament, Shadow rapporteur for opinion)

16 Nov 2023 · Agriculture

Meeting with Martin Hojsík (Member of the European Parliament, Rapporteur) and

15 Nov 2023 · Soil Health Law

Meeting with Beatrice Covassi (Member of the European Parliament, Shadow rapporteur) and

15 Nov 2023 · Public Hearing - Soil Monitoring Law

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion)

14 Nov 2023 · Pharmaceutical Package (Regulation)

Meeting with Andreas Glück (Member of the European Parliament)

13 Nov 2023 · Neue Züchtungsmethoden

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and European Federation of Pharmaceutical Industries and Associations

10 Nov 2023 · Directive on Medicinal products for human use

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

7 Nov 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

7 Nov 2023

Meeting with José Manuel Fernandes (Member of the European Parliament, Shadow rapporteur for opinion)

7 Nov 2023 · Soil monitoring law

Meeting with Nils Torvalds (Member of the European Parliament, Rapporteur)

7 Nov 2023 · UWWTD

Meeting with Jan Huitema (Member of the European Parliament, Shadow rapporteur)

7 Nov 2023 · New Genomic Techniques

Bayer urges farmer-led soil management over mandatory practices

1 Nov 2023
Feedback on — EU directive on soil monitoring, sustainable management, and contaminated site remediation.
Their ask — Bayer requests the directive recognise agricultural sustainability alongside soil health indicators, avoid mandatory practice lists, and ensure cost-effective monitoring data is accessible to farmers and service providers. They advocate for outcome-based incentives rather than prescriptive practices.123
How it helps them — This gives farmers flexibility to choose practices suited to their operations without regulatory constraints.45
Who loses — Environmental groups lose prescriptive requirements that could ensure specific conservation practices are implemented.6
Response to: Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on Soil Monitoring and Resilience (Soil Monitoring Law)

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and Acumen Public Affairs

31 Oct 2023 · Pharmaceutical Package (Regulation)

Meeting with Jan Huitema (Member of the European Parliament, Shadow rapporteur) and

24 Oct 2023 · New Genomic Techniques

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion) and Lääketeollisuus ry

13 Oct 2023 · Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

11 Oct 2023 · Pharmarevision (staff level)

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

10 Oct 2023 · Medicines

Meeting with Martin Hojsík (Member of the European Parliament, Rapporteur)

5 Oct 2023 · Soil, NGTs

Meeting with Clara Aguilera (Member of the European Parliament, Rapporteur for opinion)

28 Sept 2023 · Sustainable Use of Pesticides Regulation

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis), Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis)

4 Sept 2023 · Chemicals Strategy for Sustainability

Meeting with Suvi Leinonen (Cabinet of Commissioner Jutta Urpilainen)

26 May 2023 · Food security. Sustainable food system transformation.

Meeting with Miapetra Kumpula-Natri (Member of the European Parliament)

25 May 2023 · Meeting on EU medicine legislation

Meeting with Irène Tolleret (Member of the European Parliament) and

10 May 2023 · Pesticides

Bayer warns EU pharmaceutical taxonomy criteria are unrealistic and discourage investment

3 May 2023
Feedback on — EU Taxonomy criteria for environmentally sustainable pharmaceutical manufacturing activities.
Their ask — Bayer requests removing requirements to assess biodegradation of transformation products and metabolites, as the pharmaceutical industry lacks necessary data. They argue companies meeting other important environmental criteria would be classified as non-green due to missing this single data requirement. They propose criteria should allow APIs that are biodegradable to qualify as green without requiring comparison to competing products.123
How it helps them — This would allow pharmaceutical companies to achieve taxonomy alignment and maintain investor confidence.45
Who loses — Environmental groups lose stricter standards requiring comprehensive pollution data for pharmaceutical products.6
Response to: COMMISSION DELEGATED REGULATION (EU) …/... amending Delegated Regulation (EU) 2021/2139 as regards additional technical screening criteria for determining the conditions under which certain economic activities qualify as contributing substantially to climate change mitigation or climate change adaptation and for determining whether those activities cause no significant harm to any of the other environmental objectives

Bayer warns EU pharma taxonomy criteria are unrealistic and disincentivize innovation

2 May 2023
Feedback on — EU classification system for environmentally sustainable pharmaceutical manufacturing investments.
Their ask — Bayer requests removal of transformation products and metabolites criteria, arguing the industry lacks necessary data. They want criteria that recognize biodegradable APIs as green without additional requirements. They propose delaying reporting alignment until 2025 to match other sustainability directives.123
How it helps them — This would allow Bayer's biodegradable products to qualify as green without costly testing.45
Who loses — Environmental groups lose stronger protections against pharmaceutical pollution in waterways.
Response to: COMMISSION DELEGATED REGULATION (EU) …/... supplementing Regulation (EU) 2020/852 of the European Parliament and of the Council by establishing the technical screening criteria for determining the conditions under which an economic activity qualifies as contributing substantially to the sustainable use and protection of water and marine resources, to the transition to a circular economy, to pollution prevention and control, or to the protection and restoration of biodiversity and ecosystems and for determining whether that economic activity causes no significant harm to any of the other environmental objectives and amending Delegated Regulation (EU) 2021/2178 as regards specific public disclosures for those economic activities

Bayer urges holistic approach to chemical classification revision

30 Mar 2023
Feedback on — EU revision of chemical classification, labelling and packaging rules under CLP Regulation.
Their ask — Bayer requests that weight of evidence determinations allow consideration of all relevant information beyond simple value comparisons. They want grouping based on comprehensive data examination, not just structural similarity. They oppose direct transposition of decisions from other regulations into harmonised classifications.123
How it helps them — This would reduce false positive classifications and lower their regulatory burden.45
Who loses — Environmental and health advocates lose stricter automatic protections against hazardous chemicals.6
Response to: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

Meeting with Lukas Visek (Cabinet of Executive Vice-President Frans Timmermans)

21 Mar 2023 · Sustainable use of pesticides and new genomic techniques

Bayer urges flat baseline and flexible permanence for EU carbon farming

17 Mar 2023
Feedback on — EU regulation on certifying carbon removals from ecosystems and industrial solutions.
Their ask — Bayer requests a flat standardised baseline for arable mineral soils, flexible longevity options through monitoring extensions and portfolio-wide mechanisms, and inclusion of social and economic co-benefits alongside environmental ones. They emphasize carbon removals should supplement emissions reductions, not replace them.1234
How it helps them — This would reduce transaction costs and reward their existing carbon farming initiatives.56
Who loses — Climate integrity suffers if removals offset emissions that should be reduced instead.78
Response to: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing a Union certification framework for carbon removals

Meeting with Axel Voss (Member of the European Parliament, Shadow rapporteur) and

8 Mar 2023 · Corporate Sustainability Due Diligence

Meeting with Franc Bogovič (Member of the European Parliament, Shadow rapporteur for opinion) and Pesticide Action Network Europe

2 Mar 2023 · Meeting on SUR regulation proposal

Meeting with Christine Schneider (Member of the European Parliament)

28 Feb 2023 · CSS

Meeting with Martin Hojsík (Member of the European Parliament, Shadow rapporteur)

28 Feb 2023 · hazard classes under the EU Classification, Labelling and Packaging and pesticides

Meeting with Clara Aguilera (Member of the European Parliament, Rapporteur for opinion)

23 Feb 2023 · Draft Regulation SUR

Meeting with Adriana Maldonado López (Member of the European Parliament)

14 Feb 2023 · Reglamento del Espacio Europeo de Datos Sanitario

Meeting with Karen Melchior (Member of the European Parliament)

8 Feb 2023 · Request for early availability of guidance and recognizable standards in CSDDD

Meeting with István Ujhelyi (Member of the European Parliament)

7 Dec 2022 · Europe's Beating Cancer Plan

Meeting with Jens Gieseke (Member of the European Parliament)

7 Dec 2022 · Austausch zur Europapolitik

Meeting with Susana Solís Pérez (Member of the European Parliament, Shadow rapporteur)

30 Nov 2022 · EHDS

Meeting with Petar Vitanov (Member of the European Parliament, Shadow rapporteur)

30 Nov 2022 · EHDS

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)

30 Nov 2022 · European Health Data Space - EHDS

Meeting with Wolfgang Burtscher (Director-General Agriculture and Rural Development)

28 Nov 2022 · General agriculture of the future

Meeting with Lukas Visek (Cabinet of Executive Vice-President Frans Timmermans)

27 Oct 2022 · Sustainable food systems

Meeting with Maciej Golubiewski (Cabinet of Commissioner Janusz Wojciechowski)

27 Oct 2022 · HoCs meeting with Senior VP Bayer AG

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1272/2008 as regards hazard classes and criteria for the classification, labelling and packaging of substances and mixtures

18 Oct 2022

Meeting with Alexander Bernhuber (Member of the European Parliament, Shadow rapporteur)

18 Oct 2022 · Sustainable use of Pesticides

Meeting with Franc Bogovič (Member of the European Parliament) and CropLife Europe

18 Oct 2022 · Meeting on agriculture related legislation

Meeting with Martin Häusling (Member of the European Parliament)

12 Oct 2022 · Austausch zum Umbau der Landwirtschaft und regionalen Perspektiven

Meeting with Joanna Stawowy (Cabinet of Commissioner Janusz Wojciechowski), Jorge Pinto Antunes (Cabinet of Commissioner Janusz Wojciechowski) and

11 Oct 2022 · To discuss the contribution of innovative plant breeding to food security and sustainability to achieve the green deal objectives

Meeting with Jorge Pinto Antunes (Cabinet of Commissioner Janusz Wojciechowski) and

11 Oct 2022 · To discuss the contribution of innovative plant breeding to food security and sustainability to achieve the green deal objectives

Bayer urges impact-based pesticide rules over volume cuts

19 Sept 2022
Feedback on — EU regulation revising sustainable use of pesticides and integrated pest management.
Their ask — Bayer requests the EU shift from volume-based reduction targets to impact-based indicators measuring environmental effects. They advocate maintaining IPM as the cornerstone while promoting digital and precision farming technologies. The company seeks faster approval processes for biopesticides and exemptions allowing chemical pesticides as integrated tools, not last resort.123
How it helps them — This would allow continued sales of high-volume pesticides while shifting regulatory focus from quantity to methodology.45
Who loses — Environmental and health advocates lose clearer volume-based reduction commitments and stronger pesticide restrictions in sensitive areas.67
Response to: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the sustainable use of plant protection products and amending Regulation (EU) 2021/2115

Meeting with Jutta Urpilainen (Commissioner)

26 Aug 2022 · Factory visit as part of mission; SDGs

Meeting with Stefan Berger (Member of the European Parliament)

19 Aug 2022 · Pflanzenschutz

Bayer urges harmonized data access rules across EU health space

28 Jul 2022
Feedback on — New EU regulation on sharing and reusing electronic health data for research and care.
Their ask — Bayer requests harmonized implementation across Member States with common data standards and clear timelines. They want protection for commercially confidential clinical trial data and trade secrets. They seek unified interpretation of key terms like 'anonymisation' and 'scientific research' to enable cross-border research.1234
How it helps them — This would enable efficient global research operations and protect proprietary clinical trial information.56
Who loses — Public health authorities lose some immediate access to commercial clinical trial data.7
Response to: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

Meeting with Peter Liese (Member of the European Parliament, Rapporteur) and American Chamber of Commerce to the European Union

6 Jul 2022 · ETS

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

28 Jun 2022 · Medicines

Meeting with Axel Voss (Member of the European Parliament, Shadow rapporteur) and Verband der Chemischen Industrie e.V.

16 Jun 2022 · Corporate Sustainability Due Diligence

Bayer urges broader biodiversity focus beyond pollinators

8 Jun 2022
Feedback on — EU revision of pollinator protection strategy to reverse insect decline by 2030.
Their ask — Bayer requests the initiative expand beyond pollinators to all beneficial organisms and biodiversity. They want farmers supported in managing ecosystem services and disservices, with clear targets and public financing for habitat creation. They emphasize maintaining farm productivity through continued access to pesticides and innovation.1234
How it helps them — This would preserve their pesticide market while shifting conservation costs to public funding.567
Who loses — Environmental groups lose focused pollinator protection as emphasis shifts to broader biodiversity goals.89
Response to: Revision of the EU Pollinators Initiative

Meeting with Franc Bogovič (Member of the European Parliament)

30 May 2022 · Meeting with Bayer Crop Science on new genomic techniques

Meeting with Cristian-Silviu Buşoi (Member of the European Parliament)

11 May 2022 · health and life-science innovation, challenges of healthcare in Europe

Bayer urges EU carbon removal framework with market integration

29 Apr 2022
Feedback on — EU regulation certifying carbon removals from ecosystems and industrial solutions.
Their ask — Bayer requests a regulatory framework linked to existing emissions trading systems, result-based finance for farmers, and harmonized monitoring standards. They want certified carbon removals to be tradable in LULUCF, ESR, and eventually EU ETS markets. The framework should build on voluntary carbon markets and avoid prescribing specific farming practices.123
How it helps them — This would create market demand for their carbon farming programs across Europe.45
Who loses — Environmental groups lose stronger safeguards against avoided loss crediting and baseline manipulation.6
Response to: A European Union Regulatory Framework for the Certification of Carbon Removals

Meeting with Kathleen Van Brempt (Member of the European Parliament)

27 Apr 2022 · The Green Deal and food security

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

5 Apr 2022

Meeting with Martin Häusling (Member of the European Parliament)

25 Mar 2022 · Austausch bzgl. Bayer-Aktivitäten mit Russland infolge des Ukrainekriegs

Bayer urges result-based approach for EU Soil Health Law

11 Mar 2022
Feedback on — New EU regulation on protecting, sustainably managing and restoring EU soils.
Their ask — Bayer requests the law be result-based, setting soil health goals but leaving farming practices to farmers. They want harmonized EU soil indicators while avoiding regulatory overlap with existing directives. The company seeks flexible, risk-based approaches that enable access to necessary tools and avoid hurdles for innovation.123
How it helps them — This would preserve farmer autonomy and avoid additional testing requirements for pesticides.45
Who loses — Environmental groups lose prescriptive farming practices that could directly protect soil health.6
Response to: Proposal for a Directive on protecting, sustainably managing and restoring EU soils - Soil Health Law

Meeting with Frans Timmermans (Executive Vice-President) and

3 Dec 2021 · Discussion on investments into carbon removals with business representatives

Bayer urges private sector carbon farming incentives in LULUCF revision

3 Nov 2021
Feedback on — EU regulation on greenhouse gas removals from land use, forestry and agriculture.
Their ask — Bayer requests tools and incentives for farmers to achieve carbon removal targets through a project-based mechanism where farmers can independently register climate mitigation projects and generate tradable credits. They want carbon storage in soils and permanent vegetation explicitly recognized in the regulation, and synchronization with the Common Agricultural Policy to enable cross-eligible activities.123
How it helps them — This creates new revenue streams for Bayer's carbon farming programs and digital tools.45
Who loses — Climate advocates lose stricter emission reduction requirements in favor of offsetting flexibility.6
Response to: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EU) 2018/841 as regards the scope, simplifying the compliance rules, setting out the targets of the Member States for 2030 and committing to the collective achievement of climate neutrality by 2035 in the land use, forestry and agriculture sector, and (EU) 2018/1999 as regards improvement in monitoring, reporting, tracking of progress and review

Meeting with Axel Voss (Member of the European Parliament, Shadow rapporteur)

12 Oct 2021 · Corporate Sustainability Due Diligence

Meeting with Roberto Viola (Director-General Communications Networks, Content and Technology)

12 Oct 2021 · Health data & health data space

Bayer urges EU carbon farming incentives and harmonized certification

6 Oct 2021
Feedback on — EU consultation on carbon removal certification and carbon farming initiative.
Their ask — Bayer requests that the Commission stimulate Member State removal action, mobilize private sector involvement, and develop harmonized certification rules. They advocate for flexible trading of carbon removals across EU sectors and creating a carbon bank to purchase credits. The company emphasizes the need for cost-effective certification and capacity building for farmers.1234
How it helps them — This would create new revenue streams from carbon credits for Bayer's farming customers.56
Who loses — Environmental groups lose if flexible offsetting dilutes actual emission reduction efforts.7
Response to: Restoring a Sustainable Carbon Cycle Communication on the Carbon Removal Certification Initiative and the Carbon Farming Initiative

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... amending Implementing Regulation (EU) 2019/2072 as regards the listing of pests, prohibitions and requirements for the introduction into, and movement within, the Union of plants, plant products and other objects, and repealing Decisions 98/109/EC and 2002/757/EC and Implementing Regulations (EU) 2020/885 and (EU) 2020/1292

24 Aug 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

29 Jul 2021

Bayer urges broader farm data collection beyond organic practices

30 Jun 2021
Feedback on — EU proposal to expand farm data network to include environmental and social practices.
Their ask — Bayer requests data collection cover all farming tools and systems, not just organic methods. They want inclusion of conventional, digital, chemical, biological and mechanical practices. The company argues the current focus on Farm to Fork targets is too narrow for effective sustainability policy.12
How it helps them — This would legitimize conventional and chemical farming methods alongside organic practices in sustainability policy.34
Who loses — Environmental advocates lose emphasis on reducing pesticide and fertilizer use through targeted Farm to Fork metrics.5
Response to: Commission proposal for a Regulation of the European Parliament and of the Council setting up a network for the collection of data on the incomes, business operation, environmental practices and social aspects of agricultural holdings in the European Union

Meeting with Andrea Beltramello (Cabinet of Executive Vice-President Valdis Dombrovskis), Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis) and

28 May 2021 · Sustainable corporate governance and due diligence

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Meeting with Lukas Visek (Cabinet of Executive Vice-President Frans Timmermans)

9 Mar 2021 · Carbon farming

Meeting with Thierry Breton (Commissioner) and

8 Feb 2021 · Task Force on vaccine production

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

3 Feb 2021

Meeting with Estela Pineiro-Kruik (Cabinet of Executive Vice-President Frans Timmermans), Lukas Visek (Cabinet of Executive Vice-President Frans Timmermans)

25 Jan 2021 · Preparation of a panel discussion at the Davos summit

Response to Revision of Directive 2009/128/EC on the sustainable use of pesticides with accompanying Impact Assessment

3 Aug 2020

Response to Legislative framework for the governance of common European data spaces

31 Jul 2020

Meeting with Catherine Geslain-Laneelle (Cabinet of Commissioner Janusz Wojciechowski), Jorge Pinto Antunes (Cabinet of Commissioner Janusz Wojciechowski)

23 Jul 2020 · Bayer to share their perspectives on the Green Deal and the measures already launched at the end of May.

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020

Meeting with Dermot Ryan (Cabinet of Commissioner Phil Hogan)

24 Jun 2020 · Green deal

Response to Commission proposal for the revision of Directive 2010/75/EU on industrial emissions

21 Apr 2020

Meeting with Thierry Breton (Commissioner) and

7 Apr 2020 · The impact of COVID-19 on the built environment ecosystem

Response to Commission Communication on Europe’s Beating Cancer Action Plan

3 Mar 2020

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... establishing uniform conditions for the implementation of Regulation (EU) 2016/2031 of the European Parliament and the Council, as regards protective measures against pests of plants, and repealing Commission Regulation (EC) No 690/2008 and amending Commission Implementing Regulation (EU) 2018/2019

10 Sept 2019

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

25 Jun 2019 · Innovation in agriculture, new breding techniques

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis), Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

28 Mar 2019 · MRLs for pesticides

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis)

9 Jan 2019 · New breeding techniques

Meeting with Vytenis Andriukaitis (Commissioner) and

21 Nov 2018 · The role of transparency in scientific assessment

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

6 Nov 2018 · Preparation of Commissioner's intervention at November Bayer's event

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

25 Sept 2018 · Sustainable farming

Response to Commission Report on the final evaluation of the EU Biodiversity Strategy to 2020

2 Jul 2018

Meeting with Marika Lautso-Mousnier (Cabinet of Vice-President Jyrki Katainen) and EPPA SA

2 Mar 2018 · Crop protection industry and the Regulation 1107/2009 on the approval of active substances in the field of crop protection

Meeting with Jyrki Katainen (Vice-President) and

21 Nov 2017 · Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry

Meeting with Günther Oettinger (Commissioner)

19 Jul 2017 · Industry 4.0

Meeting with Aurore Maillet (Cabinet of Vice-President Karmenu Vella)

11 Jul 2017 · Endocrine disruption, neonicotinoids and sustainable use of pesticides

Meeting with Vytenis Andriukaitis (Commissioner) and

10 Jul 2017 · Plant protection products

Meeting with Robert Schröder (Cabinet of Commissioner Carlos Moedas)

30 May 2017 · innovative agriculture

Meeting with Léon Delvaux (Cabinet of President Jean-Claude Juncker)

25 Apr 2017 · Challenges for the agricultural sector

Meeting with Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

6 Apr 2017 · current political priorities

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

29 Mar 2017 · Endocrine disruptors, approval of plant protection products

Meeting with Phil Hogan (Commissioner)

15 Nov 2016 · Attend Reception

Response to COMMISSION REGULATION (EU) No …/.. amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

4 Oct 2016

Meeting with Günther Oettinger (Commissioner)

27 Sept 2016 · e-Health

Meeting with Jyrki Katainen (Vice-President)

27 Sept 2016 · Competitiveness

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

21 Sept 2016 · Access to Medicines, HTA

Meeting with Carlos Moedas (Commissioner)

18 Apr 2016 · Open innovation & Innovative Medicine Initiative 2 (IMI2)

Meeting with Alexander Italianer (Secretary-General Secretariat-General)

3 Dec 2015 · Business Europe CEO day

Meeting with Jyrki Katainen (Vice-President) and

3 Dec 2015 · Business Europe CEO day

Meeting with Frans Timmermans (First Vice-President)

3 Dec 2015 · Business Europe CEO day

Meeting with Carlos Moedas (Commissioner) and

3 Dec 2015 · Business Europe CEO day

Meeting with Heidi Jern (Cabinet of Vice-President Jyrki Katainen), Juho Romakkaniemi (Cabinet of Vice-President Jyrki Katainen) and BUSINESSEUROPE

27 Aug 2015 · Circular Economy

Meeting with Phil Hogan (Commissioner)

9 Jun 2015 · Agri Issues

Meeting with Günther Oettinger (Commissioner)

6 May 2015 · Digitalisierung der Industrie

Meeting with Robert-Jan Smits (Director-General Research and Innovation)

6 May 2015 · Innovation in Europe

Meeting with Carl-Christian Buhr (Cabinet of Commissioner Phil Hogan)

2 Mar 2015 · Presentation of Bayer's activities in data science ("big data on the fields"), presentation of relevant Horizon 2020 R&D&I support areas

Meeting with Tom Tynan (Cabinet of Commissioner Phil Hogan)

12 Feb 2015 · Core fields of activity of Bayer CropScience, Key regulatory framework, concerns regarding the implementation of the Plant Protection Products Regulation 1107/2009 and the Maximum Residues Level Regulation 396/2005, impact of EU regulations on trade in agricultural products and product availability for farmers, impact of the hazard-based approach and regulatory cut offs for Endocrine Disruptors, Neonicotinoids and bee health

Meeting with Robert Madelin (Director-General Communications Networks, Content and Technology) and

12 Feb 2015 · Digital Single Market, Innovation